GLP-1 Peripregnancy, Normal Tissue Characterization, and CVD Risk Assessment

from TT HealthWatch · host Christina Acosta

Program notes:0:40 CVD risk factors and texting1:40 How many undergo screening?2:41 Impact of personalized messaging3:25 Decentralized trials versus centralized 4:25 Decentralized much larger5:25 Does the trial move in one way or another?6:15 Two studies related to use of peripregnancy GLP-1 use7:15 Stopping at pregnancy8:15 Is overweight worse than stopping?9:00 Machine learning model, tissues, genetics and age10:00 Practical for assessing genetic basis11:00 Sequential tissue samples11:57 End

Episode metadata supplied by the publisher feed · Published Dec 2, 2025

Embed this episode

Attribution link and audio player

What this episode covers

This week's topics include decentralized clinical trials, GLP-1 peripregnancy, LLM and normal tissue characterization, and texting to improve CVD risk assessment.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

GLP-1 Peripregnancy, Normal Tissue Characterization, and CVD Risk Assessment

0:00 11:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TT HealthWatch?

This episode is 11 minutes long.

When was this TT HealthWatch episode published?

This episode was published on December 2, 2025.

Can I download this TT HealthWatch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!